Circuit Judge Upholds Use Of Lethal Injection Drug

Follow CBSMIAMI.COM: Facebook | Twitter

TALLAHASSEE (CBSMiami/NSF) - Setting the stage for another Florida Supreme Court death-penalty debate, a Central Florida judge has rejected Death Row inmate Jerry Correll's arguments that one of the drugs in the state's execution protocol could subject the convicted killer to cruel and unusual punishment.

Correll "has not presented sufficient scientific proof to establish that the application of Florida's lethal injection protocol is unconstitutional as applied to him," 9th Judicial Circuit Judge Jenifer M. Davis ruled last week.

The Florida Supreme Court in February put Correll's execution, which was ordered by Gov. Rick Scott in January, on hold, pending the outcome of a U.S. Supreme Court decision regarding Oklahoma's lethal-injection protocol.

In June, a bitterly divided U.S. Supreme Court signed off on the use of the drug midazolam, the first of a three-drug lethal cocktail also used in Florida.

The high court found that Oklahoma prisoners failed to prove that use of the drug "entails a substantial risk of severe pain."

After the June decision, the state Supreme Court refused to grant Attorney General Pam Bondi's request to lift the stay on Correll's execution.

Instead, the justices asked Davis to rule on Correll's arguments that midazolam poses a heightened risk to him because of his alleged brain damage and history of drug use. But Davis decided that Correll, convicted of the 1985 stabbing deaths in Orlando of his ex-wife and their 5-year-old daughter as well as his ex-mother-in-law and her sister, failed to prove that the drug was likely or very likely to have a "paradoxical" reaction on the inmate.

(TM and © Copyright 2015 CBS Radio Inc. and its relevant subsidiaries. CBS RADIO and EYE Logo TM and Copyright 2015 CBS Broadcasting Inc. Used under license. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed. The Associated Press contributed to this report.)

Read more
f

We and our partners use cookies to understand how you use our site, improve your experience and serve you personalized content and advertising. Read about how we use cookies in our cookie policy and how you can control them by clicking Manage Settings. By continuing to use this site, you accept these cookies.